OTTAWA, Canada & BERLIN, Germany — June 1, 2026 — miRoncol Health today announced a partnership with YEARS, one of Europe’s most advanced preventive medicine clinics, to bring its flagship test — miCheckUp, a microRNA Multi-Disease Screening (MMDS) test — to YEARS’ clients in Berlin. The collaboration marks the first step in miRoncol’s European journey.
The science behind miCheckUp was recognized by the 2024 Nobel Prize in Physiology or Medicine, awarded for the discovery of microRNA — small molecules that regulate gene expression and carry early signals of disease, often years before symptoms appear.
Every cell in the body releases microRNA, carrying signals about what is working, what is stressed, and what is beginning to go wrong. These signals are present in the blood long before conventional diagnostics can detect a problem. miCheckUp is built to read them.
YEARS already operates one of the most comprehensive preventive diagnostic protocols on the continent, including whole-body MRI, a panel of more than 230 biomarkers, and a full functional workup. Through the partnership, miCheckUp will join that diagnostic stack as a new layer of resolution — beginning with multi-cancer detection.
Over time, the companies plan to expand the collaboration across the four pillars of chronic disease: cancer, cardiovascular, metabolic, and neurodegenerative.
“Thank you to the miRoncol Health team. Prevention advances when innovation and scientific rigor move at the same speed. We are excited to contribute to building that evidence together in Germany and beyond.” — Prof. Jan Hennigs, Medical Director, YEARS
“The synergy between YEARS and miRoncol Health is undeniable. When two forward-thinking organizations share such a precise vision for the future of healthcare for prevention and longevity, groundbreaking innovation is inevitable. Looking forward to seeing the impact of this collaboration!” — Victoria Xu, CEO and Co-Founder, miRoncol Health
About miRoncol Health
miRoncol Health is an Ottawa-based healthtech company developing miCheckUp, an AI-powered, microRNA-based blood test for real-time, multi-cancer early risk assessment. Built on peer-reviewed research and large-scale studies, miRoncol aims to make early detection accurate, affordable, and accessible. Learn more about miRoncol Health at mironcol.com, or learn about the miCheckUp test at miCheckUp.com.
About YEARS
YEARS operates one of Europe’s most comprehensive preventive medicine protocols in Berlin, combining whole-body MRI, 230+ biomarkers, and advanced functional testing to help clients add more healthy years to their lives. Learn more at years.co.